pyrazines has been researched along with clofibrate in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Demacker, PN; Stalenhoef, AF; Stuyt, PM; Van 't Laar, A | 1 |
| Branzoli, U; Chiari, A; Lovisolo, PP; Orsini, G | 1 |
| Baer, JE; Bohn, DL; Fanelli, GM; Reilly, SS | 1 |
1 trial(s) available for pyrazines and clofibrate
| Article | Year |
|---|---|
A comparative study of the effects of acipimox and clofibrate in type III and type IV hyperlipoproteinemia.
Topics: Adult; Aged; Apolipoprotein A-I; Apolipoprotein A-II; Apolipoproteins A; Apolipoproteins B; Cholesterol; Clofibrate; Female; Humans; Hyperlipoproteinemia Type III; Hyperlipoproteinemia Type IV; Hypolipidemic Agents; Lipase; Lipoprotein Lipase; Lipoproteins; Male; Middle Aged; Pyrazines; Triglycerides | 1985 |
2 other study(ies) available for pyrazines and clofibrate
| Article | Year |
|---|---|
Effect of the antilipolytic compound acipimox on peroxisome marker enzymes, lipid pattern and biotransformation related functions in rat liver.
Topics: Animals; Biotransformation; Clofibrate; Cytochrome P-450 Enzyme System; Enzymes; Glutathione; Hypolipidemic Agents; Lipid Metabolism; Liver; Male; Microbodies; Molecular Weight; Proteins; Pyrazines; Rats | 1985 |
Renal excretion and uricosuric properties of halofenate, a hypolipidemic-uricosuric agent, in the chimpanzee.
Topics: Acetamides; Aminohippuric Acids; Animals; Carbon Isotopes; Carboxylic Acids; Clofibrate; Diuresis; Fluorine; Glycolates; Hydrogen-Ion Concentration; Hypolipidemic Agents; Kidney; Kidney Function Tests; Kidney Tubules; Kinetics; Male; Pan troglodytes; Probenecid; Pyrazines; Salicylates; Uricosuric Agents | 1972 |